The batch production and control records are deficient in that they do not include the identity ofmajor equipment used.
View the regulator's official sourceBy Country
Belgium manufacturing-site findings
at manufacturing sites in this country 42 findings drawn from 11 published documents. The most recent cases are below; the full set is in search.
See all Belgium findingsWhich agency cited it
Companies with the most findings
Recent findings
Four non-medical broken vial US complaints for Gammagard Liquid were discovered in April.
See every finding in this document View the regulator's official sourceQuality Investigations were not conducted per SOP-2024-Adverse Event Quality Investigations.
See every finding in this document View the regulator's official sourceThere is a failure to thoroughly review a batch or any of its components to meet any of its specifications Whether or not the batch has been already distributed.
See every finding in this document View the regulator's official sourceThe following corrective actions were found deficient: a.
See every finding in this document View the regulator's official sourceFailure to thoroughly investigate the presence of) _,,, in the Water for Injection (WFI) | os where sterile bukh is manufactured.
See every finding in this document View the regulator's official sourceOther countries
A record as of publication. Check the agency's own announcements for any later corrective action. Counts as of 2026-11-14.